GB201813316D0 - Multimodality treatment with Echo 7 virus and an angiogenesis inhibitor particularly bevacizumab - Google Patents
Multimodality treatment with Echo 7 virus and an angiogenesis inhibitor particularly bevacizumabInfo
- Publication number
- GB201813316D0 GB201813316D0 GBGB1813316.5A GB201813316A GB201813316D0 GB 201813316 D0 GB201813316 D0 GB 201813316D0 GB 201813316 A GB201813316 A GB 201813316A GB 201813316 D0 GB201813316 D0 GB 201813316D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- echo
- virus
- angiogenesis inhibitor
- inhibitor particularly
- multimodality treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 title 1
- 239000004037 angiogenesis inhibitor Substances 0.000 title 1
- 229960000397 bevacizumab Drugs 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2019/071519 WO2020035423A1 (en) | 2018-08-13 | 2019-08-11 | Combination therapy of cancer by administrating echo-7 virus and a pharmaceutically effective anti-cancer drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1813175.5A GB201813175D0 (en) | 2018-08-13 | 2018-08-13 | Virus use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201813316D0 true GB201813316D0 (en) | 2018-09-26 |
Family
ID=63667248
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1813175.5A Ceased GB201813175D0 (en) | 2018-08-13 | 2018-08-13 | Virus use |
| GBGB1813316.5A Ceased GB201813316D0 (en) | 2018-08-13 | 2018-08-15 | Multimodality treatment with Echo 7 virus and an angiogenesis inhibitor particularly bevacizumab |
| GBGB1813350.4A Ceased GB201813350D0 (en) | 2018-08-13 | 2018-08-15 | Multimodality treatment with echo 7 virus and an angiogenesis inhibitor particularly bevacizumab |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1813175.5A Ceased GB201813175D0 (en) | 2018-08-13 | 2018-08-13 | Virus use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1813350.4A Ceased GB201813350D0 (en) | 2018-08-13 | 2018-08-15 | Multimodality treatment with echo 7 virus and an angiogenesis inhibitor particularly bevacizumab |
Country Status (1)
| Country | Link |
|---|---|
| GB (3) | GB201813175D0 (en) |
-
2018
- 2018-08-13 GB GBGB1813175.5A patent/GB201813175D0/en not_active Ceased
- 2018-08-15 GB GBGB1813316.5A patent/GB201813316D0/en not_active Ceased
- 2018-08-15 GB GBGB1813350.4A patent/GB201813350D0/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB201813175D0 (en) | 2018-09-26 |
| GB201813350D0 (en) | 2018-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273550A (en) | Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m variation | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| IL283200A (en) | Combination for the treatment of NAFLD and NASH | |
| IL258741B (en) | Combination of bcl-2 inhibitor and mek inhibitor for the treatment of cancer | |
| IL279347A (en) | Gremlin-1 antagonist for the prevention and treatment of cancer | |
| IL275550A (en) | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer | |
| IL276535A (en) | Modified adenoviruses | |
| GB201820450D0 (en) | Compound and its use for the treatment of alpha1-antitryspin deficiency | |
| IL277749A (en) | Pladienolide compounds and their use | |
| IL281585B (en) | Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof | |
| PT3810128T (en) | Compositions for treating and/or preventing protein-aggregation diseases | |
| IL277007A (en) | Therapeutic anti-spla2-gib antibodies and the uses thereof | |
| ZA202104244B (en) | Recombinant viruses and the uses thereof | |
| GB201701745D0 (en) | Nanoparticle-based liver-targeting therapy and imaging | |
| DK3703747T3 (en) | Use of a nox4 or nox4/1 inhibitor in combination with an immunotherapeutic agent for the treatment of cancer | |
| PL3861219T3 (en) | Interlocking means and piece of furniture comprising the same | |
| PL3463469T3 (en) | Combination of ledipasvir and sofosbuvir for use in the treatment of hepatitis b virus infections in humans | |
| SG11202011170YA (en) | Antibodies against lif and dosage forms thereof | |
| SG11202000347UA (en) | A composition for treating and/or preventing hepatitis b virus infection and the use thereof | |
| EP3780371A4 (en) | ELECTRONIC TRANSFORMER AND MICROWAVE COOKER | |
| IL277128A (en) | Hepatitis b vaccines and uses of the same | |
| IL282142A (en) | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| GB201813316D0 (en) | Multimodality treatment with Echo 7 virus and an angiogenesis inhibitor particularly bevacizumab | |
| KR101912544B9 (en) | Composition for the prevention or treatment of neuropsychiatric diseases comprising accubin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |